GlassScriptPhysician profile
James Bernard Hermiller
NPI 1619943263
$307,055.62
in general payments reported to CMS, 2019-2025
22 companies · $28K in 2025
The $28K reported for 2025 was more than what 94% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72K · 2020: $39K · 2021: $85K · 2022: $48K · 2023: $21K · 2024: $14K · 2025: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $39K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Food and Beverage: $6,423 · Travel and Lodging: $5,751.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $39,375.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,850.00 |
| Food and Beverage | $6,422.61 |
| Travel and Lodging | $5,750.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $143,276.97 | 2019-2025 | Mitraclip, Triclip, Dragonfly Opstar |
| Edwards Lifesciences Corporation | $102,455.73 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Pascal |
| Medtronic Vascular, INC. | $16,327.58 | 2019-2020 | |
| Biotronik INC. | $10,117.09 | 2019-2024 | Recross, Nhancer Rx, Orsiro Mission |
| Livanova USA, INC. | $9,606.46 | 2019-2022 | |
| Medtronic, INC. | $9,548.66 | 2021-2025 | Corevalve Evolut R, Onyx Frontier |
| Boston Scientific Corporation | $5,900.74 | 2019-2025 | Watchman Access System, Synergy, Avvigo Guidance System |
| Artivion, INC. | $3,600.00 | 2020-2021 | |
| Teleflex LLC | $1,965.45 | 2023-2025 | Guideliner |
| Zoll Circulation INC | $1,125.00 | 2023 | Catheter, Therox Ds2 Console, Downstream Cartridge |
| Shockwave Medical, INC | $906.18 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| W. L. Gore & Associates, INC. | $800.00 | 2020 | |
| Philips North America LLC | $437.59 | 2019-2024 | (Bq9) Coronary Ivus |
| Abiomed | $353.75 | 2021-2025 | Impella |
| Asahi Intecc USA, INC. | $199.61 | 2025 | Asahi Coronary Wires |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acist Medical Systems, INC. | $167.01 | 2024 | |
| Biosense Webster, INC. | $94.97 | 2019 | |
| Amgen INC. | $75.52 | 2024 | |
| Siemens Medical Solutions USA, INC. | $53.27 | 2021 | |
| Abbvie INC. | $19.93 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $12.45 | 2019 | |
| Allergan, INC. | $11.66 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Hermiller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.